Supernus Pharmaceuticals logo
Supernus Pharmaceuticals SUPN
$ 36.4 1.62%

Quarterly report 2024-Q3
added 11-04-2024

report update icon

Supernus Pharmaceuticals Cash Conversion Cycle 2011-2024 | SUPN

Annual Cash Conversion Cycle Supernus Pharmaceuticals

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
416 380 284 442 626 306 337 424 786 -3.52 K - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
786 -3.52 K 47.9

Quarterly Cash Conversion Cycle Supernus Pharmaceuticals

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
392 398 474 - 470 453 404 - 288 362 478 - 341 259 357 - 263 560 754 79.3 390 448 584 81 578 651 529 67.7 278 302 367 60.8 66.7 73.4 69.6 54.1 60.1 66.3 68.5 50.5 70.2 57.1 113 44.6 367 1.64 K 1.57 K 21.4 251 - 28.1 139 - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
1.64 K 21.4 329